logo

For the Inventor, By the Inventor

Tehran, Iran

Mohammad Abdolahad

This inventor holds 34 USPTO granted patents and 20 published patent applications, primarily in Electrochemical Cancer Diagnosis. Top assignees: Nano Hesgarsazan Salamat Arya, Nano Hesgarsazan Salamat Arya Incubation Center for Medical Equipment and Devices, Nano Hesgarsazan Salamat Arya Ncubation Center for Medical Equipment and Devices. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammad Abdolahad. Retrieved from https://idiyas.com/inventor/mohammad-abdolahad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34 

% Patents Active = 47.1

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal6 out of 6 
 
Nano Hesgarsazan Salamat Arya
 patents
silverMedal4 out of 4 
 
Nano Hesgarsazan Salamat Arya Incubation Center for Medical Equipment and Devices
 patents
bronzeMedal1 out of 1 
 
Nano Hesgarsazan Salamat Arya Ncubation Center for Medical Equipment and Devices
 patent
4. 1 out of 1 
 
Nanohesgarsazan Salamat Arya Ncubation Center for Equipment and Devices
 patent
5. 20 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2015-2026

Loading Chart...
Areas of Expertise:
Electroporation
Electrochemotherapy
Cancer Detection
Electrostatic Stimulation
Cytokine Storm
Lipidomics
Metastasis Diagnosis
In-Vivo Measurement
Ultrasound-Assisted
Circulating Tumor Cells
Electromechanical Approach
Carbon Nanotubes
34 patents (USPTO):Explore Patents
1. 12746388 - Electroporation/electrochemotherapy of surgically sensitive regions (2026-09-29),
2. 12208189 - Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood (2025-01-28),
3. 12085530 - Electromechanical approach for cancer detection (2024-09-10),
4. 12035962 - Inducing internal apoptosis in malignant tumors by positive electrostatic charges (2024-07-16),
5. 11986166 - Real-time diagnosis of cancer involved sentinel lymph nodes (SLNS) based on pH sensing (2024-05-21),
6. 11911628 - Electrostatic drug delivery (2024-02-27),
7. 11898981 - Real-time and label free analyzer for in-vitro and in-vivo detecting the suspicious regions to cancer (2024-02-13),
8. 11877838 - Preventing cytokine storm in COVID-19 patients by suppressing clonal expansion in activated lymphocytes using alternating electric fields (2024-01-23),
9. 11874268 - Method and system for metastasis diagnosis and prognosis (2024-01-16),
10. 11867649 - Electrochemical lipidomics for cancer diagnosis (2024-01-09),
11. 11844955 - Electrostatic drug delivery (2023-12-19),
12. 11806140 - Measuring an electrochemical response from a three-electrode array (2023-11-07),
13. 11630079 - Electrochemical approach for COVID-19 detection (2023-04-18),
14. 11536684 - Electrochemical method and device for detecting the effect of anticancer drugs (2022-12-27),
15. 11187701 - Real-time tracing of cytokine storm in blood serum of COVID-19 patients (2021-11-30),

Mohammad Abdolahad: A Pioneering Innovator of Tehran

Mohammad Abdolahad is a highly skilled inventor from Tehran, Iran, with an impressive track record of 22 patents to his name. His work is well-known in the fields of nanotechnology, electrochemical sensors, and medical devices. He has recently made significant contributions to the fight against COVID-19 with his patented inventions including a real-time tracing of cytokine storm in blood serum of COVID-19 patients and an electrochemical probe for cancer diagnosis.

Mr. Abdolahad works at NANO Hesgarsazan Salamat Arya, an Iranian company known for pioneering innovations that have a significant impact on the medical industry. He works alongside some of the best and brightest minds in the field of medical technology, including Zohreh Sadat Miripour and Milad Gharooni.

One of his most significant inventions is the electrochemical probe for cancer diagnosis, which is a revolutionary device that can detect the early stages of cancer cells in the human body. It is noteworthy that his patented invention has the potential to be widely used by hospitals and medical centers around the globe.

Mr. Abdolahad's recent patent for tracing cytokine storms in COVID-19 patients is also an innovative solution that can help doctors and scientists better understand the disease and its effects on the human body. This invention could lead to the development of more efficient and effective treatments for COVID-19.

In conclusion, Mohammad Abdolahad is a highly skilled inventor whose cutting-edge inventions have the potential to make significant contributions to the field of medical technology. His success and the impact of his inventions are a testament to his hard work, dedication, and commitment to improving the lives of people through innovative solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…